Literature DB >> 28169580

Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part II: nasopharyngeal carcinoma.

Christopher H Chapman1, Upendra Parvathaneni2, Sue S Yom1.   

Abstract

Entities:  

Keywords:  antineoplastic agents; antineoplastic combined chemotherapy protocols cell; carcinoma; combined modality therapy; induction therapy; molecular targeted therapy; nasopharyngeal neoplasms; neoadjuvant therapy; sequential therapy; squamous; treatment outcomes

Mesh：

Year:  2017        PMID： 28169580     DOI： 10.2217/fon-2016-0544

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  2 in total

1.  Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis.

Authors:  Haimei Qin; Rong Wang; Guijiang Wei; Huaifei Wang; Guogang Pan; Rentong Hu; Yesheng Wei; Renguang Tang; Junli Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-06       Impact factor: 2.503

2.  Effect of induction chemotherapy on the quality-of-life in patients with advanced stage tongue cancer by a prospective study.

Authors:  Tao Huang; Hui Liu; Pei Zhang; Yanxia Zhao
Journal:  J Int Med Res       Date:  2018-01-14       Impact factor: 1.671
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.